PAR
Click for more information
4.35% 24.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-312

  1. Babbanap
    644 Posts.
    lightbulb Created with Sketch. 121
    clock Created with Sketch.
    19/02/24
    15:40
    Post #: 72486098
    Actually, I'm certain that at a long ago presentation we were told peer reviews would likely happen sometime this year.
    It sounded like they do take ages, so I haven't been waiting on those. The FDA feedback is foremost on my mind, and I'm going to be very surprised if it's not good news for us. One area PR and the team has excelled in is the scientific research.

    PAR Price at posting: 36.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢ 		Change
0.010(4.35%) 		Mkt cap ! $85.70M
Open High Low Value Volume
24.0¢ 25.0¢ 24.0¢ $146.6K 603.1K

Buyers (Bids)

No. Vol. Price($)
1 2 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 46898 4
View Market Depth
Last trade - 11.16am 20/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.